Clinical Trial Update: Imaging mGluR5 and Synaptic Density in Psychiatric Disorders

View source ↗

Summary

A Yale University clinical trial is evaluating imaging of metabotropic glutamate receptor 5 (mGluR5) and synaptic density in Major Depressive Disorder and Bipol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder

Snippet

Sponsor: Yale University | Conditions: Major Depressive Disorder, Bipolar Disorder | Status: ACTIVE_NOT_RECRUITING